An investment platform in development

Women's Health meets Healthcare AI.

Calabar Capital is building an allocator-led investment platform designed to provide diversified access to specialist investment managers across Women's Health and Healthcare AI.

Women's Health identifies where substantial unmet need remains. Healthcare AI expands what may now be possible.

01 — The Investment Thesis

Two powerful forces are reshaping healthcare.

Women's Health represents one of healthcare's largest areas of unmet need. Across many conditions, scientific understanding, clinical pathways and investment remain behind the scale of the patient population and economic burden.

At the same time, Healthcare AI is changing how diseases are detected, understood and treated—from diagnostics and drug discovery to clinical decision-making and care delivery.

Together, these forces are creating new possibilities across healthcare.

Women's Health identifies where change is needed. Healthcare AI expands what is possible.
Maryann Selfe and Jillian MacNab of Calabar Capital
02 — A Specialist Ecosystem

The opportunity is broad. The expertise is distributed.

Women's Health and Healthcare AI span biotechnology, pharmaceuticals, diagnostics, medical devices, digital health and care delivery. They also extend across different stages, business models and geographies.

Specialist managers bring distinct knowledge, networks and access to different parts of this opportunity. Calabar Capital partners with complementary managers and brings their expertise together within a diversified institutional portfolio.

In a fragmented market, manager selection and portfolio construction become sources of investment value.

03 — Our Approach

Specialist access. Institutional portfolio construction.

Calabar Capital is developing a multi-manager investment platform designed to bring together complementary sources of specialist healthcare expertise within one portfolio. The investment universe may include:

Women's Health managers

Dedicated investment managers focused on conditions affecting women uniquely, differently or disproportionately.

Healthcare AI managers

Specialist managers investing in the technologies transforming healthcare research, diagnostics, clinical decision-making and care delivery.

Broader healthcare specialists

Healthcare and life-sciences managers with meaningful exposure to relevant conditions, technologies or business models.

Intersection opportunities

Selected opportunities where Women's Health and Healthcare AI converge.

This approach is intended to provide diversification across managers, healthcare domains, company stages and geographies—while preserving access to specialist knowledge.

Calabar Capital founders reviewing investment materials
04 — Portfolio Architecture

From fragmented expertise to a coherent portfolio.

Specialist manager access

Access to managers with dedicated knowledge, networks and sourcing capabilities.

Manager selection and due diligence

A disciplined assessment of investment strategy, team quality, portfolio construction, differentiation and execution capability.

Diversification

Exposure across multiple managers, healthcare domains, company stages and geographies.

Portfolio construction

A deliberate approach to position sizing, risk concentration, capital pacing and the interaction between underlying strategies.

Institutional oversight

Ongoing manager monitoring, portfolio-level analysis and consolidated reporting.

Selective co-investment access

The potential to participate in selected opportunities arising from underlying manager relationships, where appropriate.

Calabar's platform and any future investment activities remain under development and subject to the completion of all applicable legal, regulatory and operational arrangements.

05 — Allocator-led by design

Calabar Capital is being built by professionals whose experience spans institutional investing, private wealth, investment governance and financial-services regulation. Our starting point is not a single technology, company or venture strategy. It is the portfolio-level question:

How can long-term investors access these opportunities with appropriate specialist expertise, diversification and institutional discipline?

Allocator judgement

Our approach is grounded in evaluating investment managers, structures and portfolios through evidence, incentives and decision-making under uncertainty.

Specialist-manager assessment

We look beyond compelling narratives and headline track records to examine where an investment advantage originates and whether it may be repeatable.

Portfolio construction

We consider each manager not only individually, but in relation to the role it could perform, its overlap with other exposures and the risks it could introduce.

Healthcare perspective

Our thinking is informed by sustained engagement with healthcare innovation, specialist investors and the structural blind spots that have left important biological differences insufficiently understood.

Maryann Selfe and Jillian MacNab in the Calabar Capital office
06 — Public Research

Building the knowledge infrastructure around Women's Health investing.

Calabar Capital's investment approach is informed by research into how institutional capital can evaluate and access emerging healthcare opportunities. Maryann publishes her public analysis through The Billion Dollar Blindspot, an independent knowledge and publishing platform covering Women's Health investing, Healthcare AI and capital allocation.

07 — The Team

Institutional investment experience meets regulatory expertise.

Maryann Selfe, Founder and Chief Investment Officer of Calabar Capital

Maryann Selfe, FCCA

Founder and Chief Investment Officer

Maryann Selfe is an institutional investor with more than twenty years of experience across private banking, wealth and asset management, portfolio construction, manager selection, investment risk and capital allocation.

Before founding Calabar Capital, she advised family offices and institutional investors and held senior investment responsibility across more than CHF 5 billion in mandates. She is the author of The Billion Dollar Blindspot and Founder and President of FemmeHealth Alliance.

Maryann Selfe on LinkedIn
Jillian MacNab, Co-Founder and Managing Partner of Calabar Capital

Jillian MacNab

Co-Founder and Managing Partner

Jillian MacNab is a Swiss financial-services lawyer with experience across investment structures, financial regulation, governance and institutional platform development.

As Co-Founder and Managing Partner of Calabar Capital, Jillian helps shape the firm's governance, organisational development and operating structure. She works alongside Maryann to translate the investment strategy into a credible, institutionally robust platform designed to meet the expectations of investors, regulators and strategic partners.

Jillian MacNab on LinkedIn
08 — Connected, With Distinct Roles

Investment infrastructure requires more than capital.

Calabar Capital forms part of a wider body of work focused on strengthening the Women's Health investment ecosystem.

Calabar Capital

The institutional investment platform.

The Billion Dollar Blindspot

The public research, publishing and intellectual platform.

FemmeHealth Alliance

An independent non-profit organisation focused on ecosystem development, education, collaboration and convening.

Each organisation has a distinct role. Together, they contribute to the knowledge, relationships and investment infrastructure needed for capital to participate more confidently in Women's Health.

09 — Contact

Start a conversation.

Enquiries
hello@calabarcapital.com
Office
Zurich
Contact FormConfidential

Enquiry form

This form is provided by Typeform. To load it, please allow functional and embedded-content cookies.